EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Impact of Switching from Omalizumab to Dupilumab in Severe Asthma Patients: A Retrospective Evaluation of Efficacy and Inflammatory Biomarkers

Sunday 15 Jun, 12:45 PM - 12:45 PM Glasgow, United Kingdom